Search Results - Nofar Atari

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations by Nofar Atari, K. Shanmugha Rajan, Vaibhav Chikne, Smadar Cohen-Chalamish, Tirza Doniger, Odelia Orbaum, Avi Jacob, Inna Kalt, Shulamit Michaeli, Ronit Sarid

    Published in Viruses (2022-08-01)
    Get full text
    Article


  2. 2

    Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic by Michal Stein, Hodaya Cohen, Ital Nemet, Nofar Atari, Limor Kliker, Ilana S. Fratty, Efrat Bucris, Miranda Geva, Ella Mendelson, Neta Zuckerman, Michal Mandelboim

    Get full text
    Article


  3. 3

    Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity by Alona Kuzmina, Dina Korovin, Ido Cohen lass, Nofar Atari, Aner Ottolenghi, Pan Hu, Michal Mandelboim, Benyamin Rosental, Elli Rosenberg, Felipe Diaz-Griffero, Ran Taube

    Published in Heliyon (2023-06-01)
    Get full text
    Article


  4. 4

    Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season by Stephen Moss, Menucha Jurkowicz, Ital Nemet, Nofar Atari, Limor Kliker, Bayan Abd-Elkader, Tal Gonen, Emily Toth Martin, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim

    Published in Vaccines (2023-10-01)
    Get full text
    Article


  5. 5

    Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern by Abigael E. Chaouat, Ilija Brizic, Paola Kucan Brlic, Nofar Atari, Limor Kliker, Or Alfi, Michal Mandelboim, Dana Wolf, Laith Tafish, Inbal Kol, Stipan Jonjic, Ofer Mandelboim

    Published in iScience (2022-09-01)
    Get full text
    Article


  6. 6

    Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic by Ilana S. Fratty, Ilana S. Fratty, Menucha Jurkowicz, Menucha Jurkowicz, Neta Zuckerman, Neta Zuckerman, Ital Nemet, Nofar Atari, Limor Kliker, Lea Gur-Arie, Alina Rosenberg, Aharona Glatman-Freedman, Aharona Glatman-Freedman, Yaniv Lustig, Yaniv Lustig, Michal Mandelboim, Michal Mandelboim

    Published in Frontiers in Microbiology (2024-01-01)
    Get full text
    Article


  7. 7

    Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic by Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, Saritte Perlman, Yonatan Amir, Sophy Goren, Anya Bialik, Limor Kliker, Nofar Atari, Ruti Yshai, Yona Zaide, Hadar Marcus, Noa Madar-Balakirski, Tomer Israely, Nir Paran, Oren Zimhony, Eilat Shinar, Yasmin Maor, Khitam Muhsen

    Get full text
    Article


  8. 8

    High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients by Yana Davidov, Victoria Indenbaum, Nofar Atari, Limor Kliker, Keren Tsaraf, Keren Asraf, Oranit Cohen-Ezra, Mariya Likhter, Orna Mor, Ram Doolman, Yael Weiss-Ottolenghi, Tammy Hod, Arnon Afek, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim, Ziv Ben-Ari

    Published in Viruses (2022-12-01)
    Get full text
    Article


  9. 9

    Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study by Avraham Abutbul, Helena Mumblat, Yaara Porat, Nehemya Friedman, Nofar Atari, Shirley Sharabi, Ahmad Nama, Waseem Mugahed, Asa Kessler, Yotam Kolben, Reuben Ruby Shamir, Doron Manzur, Ori Farber, Liora Bosch, Gitit Lavy-Shahaf, Eyal Dor-On, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti, Yael Mardor, Yael Mardor, Michal Mandelboim, Michal Mandelboim

    Published in Frontiers in Microbiology (2023-11-01)
    Get full text
    Article


  10. 10

    Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study by Avner Ehrlich, Konstantinos Ioannidis, Makram Nasar, Ismaeel Abu Alkian, Yuval Daskal, Nofar Atari, Limor Kliker, Nir Rainy, Matan Hofree, Sigal Shafran Tikva, Inbal Houri, Arrigo Cicero, Chiara Pavanello, Cesare R Sirtori, Jordana B Cohen, Julio A Chirinos, Lisa Deutsch, Merav Cohen, Amichai Gottlieb, Adina Bar-Chaim, Oren Shibolet, Michal Mandelboim, Shlomo L Maayan, Yaakov Nahmias

    Published in eLife (2023-01-01)
    Get full text
    Article


Search Tools: